26Serious

Lomas de Zamora

Ask VT AI

View News Summary

Nippon Steel fights Biden's block of its $14.1 billion acquisition of U.S. Steel, claiming political motives and filing lawsuits to challenge the decision.
Denali Therapeutics' experimental ALS drug DNL343 fails to meet primary and secondary endpoints in a Phase II/III trial, raising concerns about the company's prospects in ALS treatment development.
Meta shifts content moderation, ending fact-checking for 'Community Notes' system to enhance free expression.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Nippon Steel fights Biden's block of its $14.1 billion acquisition of U.S. Steel, claiming political motives and filing lawsuits to challenge the decision.
Denali Therapeutics' experimental ALS drug DNL343 fails to meet primary and secondary endpoints in a Phase II/III trial, raising concerns about the company's prospects in ALS treatment development.
Meta shifts content moderation, ending fact-checking for 'Community Notes' system to enhance free expression.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Lomas de Zamora